Endothelial Progenitor Cells as a Therapeutic Option in Peripheral Arterial Disease

被引：56

作者：

Devanesan, A. J. ^{[1
]}

Laughlan, K. A. ^{[1
]}

Girn, H. R. S. ^{[1
]}

Homer-Vanniasinkam, S. ^{[1
]}

机构：

[1] Leeds Gen Infirm, Leeds Vasc Inst, Leeds LS1 3EX, W Yorkshire, England

来源：

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY | 2009年 / 38卷 / 04期

关键词：

Progenitor cells; Stem cell therapy; Ischaemia; Peripheral arterial disease; MARROW MONONUCLEAR-CELLS; UMBILICAL-CORD BLOOD; LIMB ISCHEMIA; GROWTH-FACTOR; AUTOLOGOUS TRANSPLANTATION; CARDIOVASCULAR RISK; HEART-DISEASE; STEM-CELLS; ANGIOGENESIS; IMPLANTATION;

D O I：

10.1016/j.ejvs.2009.05.019

中图分类号：

R61 [外科手术学];

学科分类号：

100210 [外科学];

摘要：

Background: Endothelial progenitor cells (EPC) are a subpopulation of bone-marrow mononuclear cells that are capable of generating new blood vessels in areas of ischaemia or infarction. This review examines the regenerative potential of EPC to ameliorate peripheral ischaemia. Methods: An online search was done using OVID Medline Search, PubMed, and Cochrane Review Database, for all reviews and original articles in English concerning progenitor or bone-marrow mononuclear cells. Results and conclusion: There are many controversies in EPC research, especially in the areas of identification, characterization, and therapeutic use. Both animal and human studies have shown benefits from using EPC to combat peripheral arterial and cerebrovascular disease. To bring EPC into wider clinical use, larger controlled clinical trials and better methods of augmenting EPC function and lifespan are required. Until then EPC should be used under robust trial conditions with ethical approval. (c) 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

引用

页码：475 / 481

页数：7

共 49 条

[1]

Mobilizing endothelial progenitor cells [J].

Aicher, A ;

Zeiher, AM ;

Dimmeler, S .

HYPERTENSION, 2005, 45 (03) :321-325

[2]

Isolation of putative progenitor endothelial cells for angiogenesis [J].

Asahara, T ;

Murohara, T ;

Sullivan, A ;

Silver, M ;

vanderZee, R ;

Li, T ;

Witzenbichler, B ;

Schatteman, G ;

Isner, JM .

SCIENCE, 1997, 275 (5302) :964-967

[3]

ASSMUS B, 2002, CIRCULATION, V106, P1913

[4]

Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure -: Results of the TOPCARE-CHD registry [J].

Assmus, Birgit ;

Fischer-Rasokat, Ulrich ;

Honold, Joerg ;

Seeger, Florian H. ;

Fichtlscherer, Stephan ;

Tonn, Torsten ;

Seifried, Erhard ;

Schaechinger, Volker ;

Dimmeler, Stefanie ;

Zeiher, Andreas M. .

CIRCULATION RESEARCH, 2007, 100 (08) :1234-1241

[5]

Assmus B, 2008, CIRCULATION, V118, pS400

[6]

Angiogenesis assays: A critical overview [J].

Auerbach, R ;

Lewis, R ;

Shinners, B ;

Kubai, L ;

Akhtar, N .

CLINICAL CHEMISTRY, 2003, 49 (01) :32-40

[7]

Stem cells and the regeneration of the aging cardiovascular system [J].

Ballard, Victoria L. T. ;

Edelberg, Jay M. .

CIRCULATION RESEARCH, 2007, 100 (08) :1116-1127

[8]

RETRACTED: Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia (Retracted Article. See vol 119, pg 545, 2010) [J].

Chen, JZ ;

Zhang, FR ;

Tao, QM ;

Wang, XX ;

Zhu, JH ;

Zhu, JH .

CLINICAL SCIENCE, 2004, 107 (03) :273-280

[9]

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice [J].

Couffinhal, T ;

Silver, M ;

Kearney, M ;

Sullivan, A ;

Witzenbichler, B ;

Magner, M ;

Annex, B ;

Peters, K ;

Isner, JM .

CIRCULATION, 1999, 99 (24) :3188-3198

[10]

Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/WOR diabetic rat [J].

Ellis, EA ;

Guberski, DL ;

Somogyi-Mann, M ;

Grant, MB .

FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (01) :91-101

← 1 2 3 4 5 →